Differentials in prevalence and correlates on uptake of tetanus toxoid and intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy: A community-based cross-sectional study in The Gambia

listen audio

Study Justification:
– The study aimed to examine the differentials in prevalence and correlates of tetanus toxoid (TT) uptake and intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) among pregnant women in The Gambia.
– The study used secondary data from The Gambia Multiple Indicators Cluster Survey (MICS) 2018, which provided nationally representative estimates for children and women across local government areas.
– The study contributes to strengthening the national statistical capacity and provides technical guidance on the quality of survey information, statistical tracking, and data collation and analysis.
– The study addresses the need for internationally comparable data collection on key indicators related to maternal and child health.
Study Highlights:
– The prevalence of TT uptake among women in The Gambia was 88.2%, while the prevalence of adequate TT doses was 34.8%.
– The prevalence of IPTp-SP uptake among maternal women in The Gambia was 98.6%, while the prevalence of adequate IPTp-SP doses taken was 34.3%.
– Statistically significant covariates of TT immunization and IPTp-SP uptake included women’s age, local government areas, parity, use of radio, use of newspaper, and antenatal care visits.
– The current utilization rate for adequate IPTp-SP and TT immunization during pregnancy in The Gambia is very low and below universal levels.
Study Recommendations:
– Strengthen mass media advocacy programs targeting both rural and urban populations to motivate maternal women to ensure adequate vaccination against malaria and tetanus.
– Implement effective strategies to improve access to and utilization of antenatal care services, including TT immunization and IPTp-SP.
– Enhance awareness and education campaigns on the importance of TT immunization and IPTp-SP among pregnant women and healthcare providers.
– Conduct further research to explore barriers and facilitators to TT immunization and IPTp-SP uptake in The Gambia.
Key Role Players:
– Ministry of Health
– National Immunization Program
– National Malaria Control Program
– Local government authorities
– Healthcare providers
– Community health workers
– Non-governmental organizations (NGOs) working in maternal and child health
Cost Items for Planning Recommendations:
– Development and implementation of mass media advocacy programs
– Training and capacity building for healthcare providers and community health workers
– Awareness and education campaigns
– Procurement and distribution of TT vaccines and IPTp-SP
– Monitoring and evaluation activities
– Research and data collection on barriers and facilitators to TT immunization and IPTp-SP uptake

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is based on a community-based cross-sectional study in The Gambia, using data from The Gambia Multiple Indicators Cluster Survey. The study analyzed data from 6143 women of reproductive age who have given birth. The prevalence rates of tetanus toxoid and intermittent preventive treatment with sulfadoxine-pyrimethamine uptake among pregnant women in The Gambia were reported, along with statistically significant covariates. The study used a multivariable logistic regression model to calculate adjusted odds ratios. The evidence is based on a large sample size and statistical analysis, which adds strength to the findings. However, the abstract does not provide information on the representativeness of the sample or the response rate. To improve the evidence, future studies should include information on the sampling methodology and response rate to ensure the findings are generalizable to the population. Additionally, providing more details on the statistical methods used and addressing potential limitations would further strengthen the evidence.

Objectives: The study examined the differentials in prevalence and correlates on the uptake of tetanus toxoid and intermittent preventive treatment of malaria among pregnant women in The Gambia. Methods: The 2018 data from The Gambia Multiple Indicators Cluster Survey were analyzed. Data from 6143 women of reproductive age who have given birth were extracted for the analysis. Percentages and Chi-square tests were used. In addition, a multivariable logistic regression model was used to calculate the adjusted odds ratios (with a corresponding 95% confidence interval). The level of significance was set at p < 0.05. Results: The prevalence of tetanus toxoid uptake among women in The Gambia was 88.2%, while that of the adequate tetanus toxoid doses was 34.8%. The prevalence of intermittent preventive treatment with sulfadoxine-pyrimethamine uptake among maternal women in The Gambia was 98.6%, while that of the adequate intermittent preventive treatment with sulfadoxine-pyrimethamine doses taken was 34.3%. The identified statistically significant covariates of tetanus toxoid immunization and intermittent preventive treatment with sulfadoxine-pyrimethamine uptake includes women’s age, local government areas, parity, use of radio, use of newspaper, and antenatal care visits. Conclusion: The current utilization rate for adequate intermittent preventive treatment with sulfadoxine-pyrimethamine and tetanus toxoid immunization during pregnancy in The Gambia is very low and even below universal levels. The country needs to strengthen more and effective mass media advocacy programs that would target both rural and urban populace, and motivate maternal women to ensure adequate vaccination against malaria and tetanus.

Secondary data from The Gambia MICS 2018 were used. 27 The data from 6143 women of reproductive age who have given birth were extracted for the analysis with a response rate of 95.4% of the original survey size of 13,640 women (age 15–49 years). 27 The Gambia MICS carried out in 2018 provided the opportunity to strengthen the national statistical capacity by providing technical guidance on the quality of survey information, statistical tracking, as well as data collation and analysis. The MICS ensures the measurement of key pointers which countries depend upon to generate data that are used in policy formulations and program planning to monitor their progress in achieving the sustainable development goals, as well as the national development plan (NDP) of The Gambia and other international commitments which the country is a signatory to. The contribution of the MICS on the strengthening of The Gambian’s improvement on data and systems monitoring and the provision of technical expertise in the design, implementation, and analysis of such systems. The major reason for the development of the MICS program by the United Nations Children’s Fund (UNICEF) was to assist countries in internationally comparable data collection on an extensive variety of indicators ranging from data on children to that of women. The Gambia MICS 2018 is a cross-sectional stratified survey designed to provide nationally representative estimates for children and women across local government areas (LGAs): Banjul, Kanifing, Brikama, Mansakonko, Kerewan, Kuntaur, Janjanbureh, and Basse. The urban and rural areas in each LGA have been designated as the principal sampling stratum. A two-stage sampling technique for the systemic selection of households was applied. The first step randomly selected enumeration areas (EAs), and clusters from each substratum were probability proportionate to the size of the 390 EAs identified in the MICS. 27 A systemic sample of 20 households was obtained in each enumeration area following household listing in the designated enumeration areas. During the fieldwork period, all the selected EAs were visited. This was the sixth round of MICS for The Gambia conducted by The Gambia Bureau of Statistics with technical support from UNICEF. A comprehensive sampling frame, error estimates, and allocation in their weighted forms as clearly presented in Appendix A of The Gambia MICS 2018 report from page 424 to 431. 27 Several other published articles only and briefly described the section as shown in several studies in The Gambia.31–33 The two dependent variables used for this study are not in variance with the previous study. 6 These two variables were uptake of TT and Fansidar (SP) during their last pregnancy. The question that participants were asked was whether or not they took TT vaccination and used IPTp-SP during their last pregnancy. Based on WHO recommendation, a minimum of (at least two doses) of TT was defined as adequate, and (at least three doses) of IPTp-SP were also determined as adequate. Below those values are regarded as inadequate doses for both IPTp-SP and TT. Thus, doses that are less than those stated above were considered inadequate. The maternal age was grouped as (15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49 years); residency: urban versus rural; LGA: Banjul, Kanifing, Brikama, Mansakonko, Kerewan, Kuntaur, Janjanbureh, Basse; education level: none, primary, secondary+; ethnicity: Mandinka, Wollof, Fula, Jola, Sarehule, Others, Non-Gambian; household wealth status: poorest, second, middle, fourth, richest; parity: 0–3, 4, and above; reading newspaper: do not use, few days a week, almost every day; listening to the radio: do not use, few days a week, almost every day; watching TV: do not use, few days a week, almost every day; ANC visits: less than five, five, and above; and currently pregnant: yes versus no. These inclusions of variables were as a result of the examined factors associated with the utilization of IPTp-SP and TT vaccination in previous studies.6,23 The original survey was conducted after being ethically approved by The Gambia Government Joint Research Ethics Committee (Ref. No: SCC1570v1.1). Before analysis, we obtained permission from The Gambia Bureau of Statistics and MICS program to access the dataset. The issue of privacy of the respondents was considered such that exclusive information such as respondents’ locations and their names as collected during the MICS interviews were consciously removed from datasets. It is also on record that participants’ consent was obtained either through signing or thumbprinted before their participation in the survey. For underage children, the adult’s consent was gotten in advance of the child’s assent. Prevalence rates of taking TT vaccination and IPTp-SP for each explanatory variable were shown as percentages in their weighted forms. The collinearity testing method was adopted in the correlation analysis to distinguish the interdependencies that exist between variables. To examine the multicollinearity that causes major concerns, a cutoff of 0.7 was used. 34 No variable from the correlation matrix was removed in the model as a result of a lack of multicollinearity. Chi-square bivariate tests were used to examine the association at p value <0.05. Controlled variables that showed p value <0.15 including those that had significant associations in the bivariate tests were included in the multivariable logistic regression model to compute the adjusted odds ratios with corresponding 95% confidence interval (CI) of the factors (covariates) associated with taking TT vaccinations and IPTp-SP. Statistical significance was set at a p value of <0.05 for all analyses. Data analysis was performed using IBM SPSS version 25.

N/A

Based on the information provided, it is difficult to identify specific innovations for improving access to maternal health. However, some potential recommendations based on the study findings and context in The Gambia could include:

1. Strengthening mass media advocacy programs: Develop and implement effective mass media campaigns targeting both rural and urban populations to raise awareness about the importance of adequate vaccination against malaria and tetanus during pregnancy.

2. Community-based interventions: Implement community-based interventions to increase awareness and knowledge about maternal health, including the benefits of tetanus toxoid immunization and intermittent preventive treatment with sulfadoxine-pyrimethamine. This could involve engaging community leaders, traditional birth attendants, and local health workers to promote and provide information on these interventions.

3. Improving antenatal care services: Enhance the quality and accessibility of antenatal care services by ensuring that all pregnant women have access to regular check-ups, counseling, and education on maternal health, including the importance of tetanus toxoid immunization and intermittent preventive treatment with sulfadoxine-pyrimethamine.

4. Addressing barriers to access: Identify and address barriers that prevent pregnant women from accessing maternal health services, such as geographical distance, transportation issues, cost, and cultural beliefs. This could involve providing transportation support, reducing or eliminating fees for maternal health services, and conducting community sensitization programs to address cultural barriers.

5. Strengthening data collection and monitoring systems: Improve the national statistical capacity by investing in data collection and monitoring systems to track progress in maternal health indicators. This could involve training health workers on data collection methods, ensuring accurate and timely reporting of maternal health data, and using data to inform policy and program planning.

It is important to note that these recommendations are general and may need to be tailored to the specific context and needs of The Gambia. Additionally, further research and consultation with relevant stakeholders would be necessary to develop and implement specific innovations for improving access to maternal health in the country.
AI Innovations Description
Based on the information provided, the recommendation to improve access to maternal health in The Gambia is to strengthen mass media advocacy programs targeting both rural and urban populations. These programs should aim to motivate maternal women to ensure adequate vaccination against malaria and tetanus. The current utilization rate for adequate intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and tetanus toxoid (TT) immunization during pregnancy in The Gambia is very low and below universal levels. By implementing effective mass media advocacy programs, more women can be reached and educated about the importance of these interventions, ultimately increasing their uptake and improving maternal health outcomes.
AI Innovations Methodology
Based on the provided description, here are some potential recommendations to improve access to maternal health:

1. Strengthen mass media advocacy programs: Develop and implement more effective mass media campaigns that target both rural and urban populations in The Gambia. These campaigns should focus on raising awareness about the importance of maternal health, including adequate vaccination against malaria and tetanus.

2. Improve antenatal care services: Enhance the quality and accessibility of antenatal care services in The Gambia. This can be achieved by increasing the number of healthcare facilities, ensuring availability of trained healthcare professionals, and providing comprehensive antenatal care packages that include education on maternal health and vaccinations.

3. Community engagement and education: Engage local communities and community leaders to promote maternal health and encourage pregnant women to seek appropriate healthcare services. Conduct educational sessions and workshops to provide information on the benefits of tetanus toxoid and intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy.

4. Strengthen data collection and monitoring systems: Improve the collection, analysis, and utilization of data related to maternal health. This can be done by enhancing the national statistical capacity, providing technical guidance on data quality, and implementing systems to track progress in achieving maternal health goals.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Baseline assessment: Collect data on the current utilization rates of tetanus toxoid and intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy in The Gambia. This can be done through surveys or analysis of existing data sources.

2. Define indicators: Identify key indicators to measure the impact of the recommendations, such as the percentage increase in tetanus toxoid uptake or the reduction in inadequate doses of sulfadoxine-pyrimethamine.

3. Develop a simulation model: Create a simulation model that incorporates the baseline data and the potential impact of the recommendations. This model should consider factors such as population demographics, healthcare infrastructure, and the effectiveness of the proposed interventions.

4. Run simulations: Use the simulation model to run multiple scenarios, varying the parameters related to the recommendations. This will allow for the estimation of the potential impact on improving access to maternal health.

5. Analyze results: Analyze the simulation results to determine the projected changes in maternal health outcomes. This can include assessing the percentage increase in vaccination rates, the reduction in inadequate doses, or any other relevant indicators.

6. Validate and refine the model: Validate the simulation model by comparing the projected results with real-world data or expert opinions. Refine the model as necessary to improve its accuracy and reliability.

7. Communicate findings: Present the findings of the simulation analysis to stakeholders, policymakers, and healthcare professionals. Use the results to advocate for the implementation of the recommended interventions and to guide decision-making processes.

It is important to note that the methodology for simulating the impact of recommendations may vary depending on available data, resources, and specific objectives. The steps outlined above provide a general framework for conducting such an analysis.

Partilhar isto:
Facebook
Twitter
LinkedIn
WhatsApp
Email